McKesson Presents Innovative Solutions at ASHP Midyear Clinical Meeting

will showcase its clinical expertise and comprehensive suite of
technology solutions at the American Society of Health-System
Pharmacists (ASHP) Midyear
Clinical Meeting
December 2 – 6. These solutions, presented by
McKesson experts, will be display and available to demo at Booth #351.

“With the continued evolution of payment models and reduced
reimbursement, hospitals and health systems are increasingly looking to
enhance their revenue recovery management to help control costs and
increase revenue while they continue to focus on quality patient care,”
said Scott Miller, president of Health Systems, McKesson. “We are
committed to delivering impactful results for our customers, and we are
honored ASHP is featuring a number of abstracts that highlight McKesson
customers and solutions.”

Presenting innovative cost savings

ASHP will feature McKesson customers and solutions covering the
following topics:

Integrating 340B into the health system pharmacy supply chain
Wilson, PharmD, FASHP, vice president of 340B Solutions at McKesson,
will participate in several book signings and ‘meet the author’ events
promoting his 340B
Program Handbook
. The handbook, developed in partnership with ASHP
and published in 2018, is a practical guide for pharmacy leaders,
hospital administrators, business managers and pharmacy supply chain
professionals implementing, maintaining or overseeing a high-performing
340B program.

Rationale and cost savings of a conversion to fluticasone-vilanterol
inhaler in a large health system

Monday, December 3, 2:30 –
4:00 p.m., Hall E, lower level

Sentara Healthcare’s pharmacy
department worked with McKesson to identify trends and opportunities to
decrease drug spend using Spend Analytics. The review identified the
inhaled corticosteroid/long-acting beta-agonist inhalers (ICS/LABA)
spend as one of the top drug spends, top increasing drug spends, and was
considered elevated due to the cost of the fluticasone-salmeterol discus
inhalers. This prompted the customer to implement a conversion from one
ICS/LABA inhaler to another, which saved them more than $656,000 in the
first year.

Dose rounding policy results in significant cost savings
December 4, 2:30 – 4:00 p.m., Hall E, lower level

Rising drug
spend requires health systems to continuously evaluate spending and
implement cost savings initiatives. Kalispell Regional Medical Center
worked with McKesson to evaluate the cost savings of a dose rounding
policy. Cost savings were calculated by comparing the prescribed and
adjusted doses. Actual acquisition costs were used to calculate savings.
The dose rounding policy implemented at Kalispell Regional Medical
Center resulted in more than $134,000 in savings to the hospital over
six months. Based on these results, the pharmacy department plans to
expand the dose rounding policy.

Demonstrating technology solutions

McKesson business and technology solutions featured at ASHP include:

  • McKesson
    will highlight improved financial and
    operational outcomes through its evidence-based programs, products and
    services including pharmacy revenue cycle analysis and indigent drug
    recovery solutions. Supply chain management solutions include revenue
    generation and recovery solutions
    that leverage data and help
    pharmacies make better decisions to support patient care.
  • McKesson
    High Volume Solutions
    will feature its custom central fill solutions including the unique
    financing model, CFaaS® (Central Fill as a Service), which
    allows outpatient pharmacies to realize the benefits of central fill
    for a small per-script fee that is lower than their current cost to
  • Macro
    , a McKesson company, will feature solutions to help
    covered entities maximize 340B program participation with
    industry-leading software and services that target the operational,
    financial and regulatory complexities to maintain compliance, ensure
    reimbursement and help health systems improve patient access to
    affordable healthcare.
  • McKesson
    Pharmacy Systems
    will provide live demos of the EnterpriseRx®
    pharmacy management system and its integrated Patient Engagement and
    Clinical Solutions. The centralized pharmacy management system can
    help simplify workflow, and, with Clinical Programs Solution™, allow
    users to add pre-configured or custom programs to help improve patient
    outcomes and maximize operational and clinical performance.
  • PipelineRx®,
    a McKesson Ventures-backed portfolio company, will highlight its
    expanded strategy to achieve integrated medication management across
    care settings. The company’s Patient Discharge Solution empowers
    pharmacists to improve access and adherence to medication protocols
    after discharge, which can improve patient outcomes and decrease
    preventable readmissions.

About McKesson Corporation

McKesson Corporation, currently ranked 6th on the FORTUNE
500, is a global leader in healthcare supply chain management solutions,
retail pharmacy, community oncology and specialty care, and healthcare
information technology. McKesson partners with pharmaceutical
manufacturers, providers, pharmacies, governments and other
organizations in healthcare to help provide the right medicines, medical
products and healthcare services to the right patients at the right
time, safely and cost-effectively. United by our ICARE shared
principles, our employees work every day to innovate and deliver
opportunities that make our customers and partners more successful — all
for the better health of patients. McKesson has been named the “Most
Admired Company
” in the healthcare wholesaler category by FORTUNE, a
Place to Work
” by the Human Rights Campaign Foundation, and a top military-friendly
 by Military Friendly. For more information, visit

© 2018 McKesson Corporation and/or one of its subsidiaries. This release
may be freely republished, with attribution, in whole or in part.